Veronique Fritz

IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide‐dexamethasone therapy in multiple myeloma

M. Willheim, H. Ludwig, K. Schlangen, 2017, American journal of hematology.

Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma

O. Berlanga, H. Ludwig, N. Zojer, 2015, American journal of hematology.